South Africa’s role in COVID-19 vaccine trials

11 September 2020 | Story Ozayr Patel. Photo CDC, Unsplash. Read time 3 min.
 

South Africa is one of the countries where trials are under way to find an efficacious vaccine against SARS-CoV-2, the virus that causes COVID-19 disease. South Africa’s participation in these trials is crucial. These vaccines are produced in the West and it’s important that they prove to be safe and effective in African countries. Participation in the trials also means that should a vaccine prove to work, the country may have easier access to it.

In today’s episode of Pasha, Professor Linda-Gail Bekker and Professor Keertan Dheda at the University of Cape Town discuss why vaccine trials are important and why South Africa needs to be involved.

This article was published in The Conversation, a collaboration between editors and academics to provide informed news analysis and commentary. Its content is free to read and republish under Creative Commons; media who would like to republish this article should do so directly from its appearance on The Conversation, using the button in the right-hand column of the webpage. UCT academics who would like to write for The Conversation should register with them; you are also welcome to find out more from lisa.boonzaier@uct.ac.za.

For licensing information please visit the source website.

Research & innovation




UCT aspires to become a premier academic meeting point between South Africa, the rest of Africa and the world. Taking advantage of expanding global networks and our distinct vantage point in Africa, we are committed , through innovative research and scholarship, to grapple with the key issues of our natural and social worlds. We are committed both to protecting and encouraging 'curiosity-driven research' and research that has a real impact on our communities and environment.



 

 




 
TOP